Cargando…

Liquid Biopsies in Progressing Metastatic Colorectal Cancer- Application and their Therapeutic Implications According to the RAS Status

Introduction The treatment of metastatic colorectal cancer (mCRC) now includes therapy with biological agents inthe first line of treatment. The advances of our knowledge in molecular biology of these tumors allowed the identification of signaling pathways involved in tumorigenesis as potential ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, José, Alves, Fatima, Ferreira, Filipa, Vasconcelos de Matos, Leonor, Massena, Ana, Martins, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082790/ https://www.ncbi.nlm.nih.gov/pubmed/32211268 http://dx.doi.org/10.7759/cureus.7035

Ejemplares similares

Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer
por: Klein-Scory, Susanne, et al.
Publicado: (2020)

Therapeutic Futility in Terminal Cancer Patients: A Retrospective and Observational Study
por: Graça, Joana, et al.
Publicado: (2021)

Prognostic Impact of Type 2 Diabetes in Metastatic Colorectal Cancer
por: Miranda Baleiras, Mafalda, et al.
Publicado: (2023)

The Metastatic Cascade as the Basis for Liquid Biopsy Development
por: Eslami-S, Zahra, et al.
Publicado: (2020)

Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients
por: Mariani, Stefano, et al.
Publicado: (2022)

Evaluating the Optimal Sequence of Treatment With EGFR Inhibitors and Bevacizumab in RAS Wild-Type Metastatic Colorectal Cancer
por: Martins, Diana, et al.
Publicado: (2022)

Perspectives in the Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer Patients
por: Rosati, Gerardo, et al.
Publicado: (2021)

The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
por: Fattore, Luigi, et al.
Publicado: (2021)

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)

Editorial: Recent advances in liquid biopsy in colorectal cancer
por: Cardone, Claudia, et al.
Publicado: (2022)

Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

Evaluation of RAS Mutational Status in Liquid Biopsy to Monitor Disease Progression in Metastatic Colorectal Cancer Patients
por: Lastraioli, Elena, et al.
Publicado: (2023)

Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer
por: Nicolazzo, Chiara, et al.
Publicado: (2023)

RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study
por: Nicolazzo, Chiara, et al.
Publicado: (2022)

Editorial: Liquid biopsy: A tool for better understanding of the metastatic process ecosystem
por: Bocci, Matteo, et al.
Publicado: (2022)

Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients
por: Salvatore, Lisa, et al.
Publicado: (2023)

Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches
por: Ceccon, Carlotta, et al.
Publicado: (2022)

A Trial Protocol of Precision Medicine for Patients with RAS Wild Metastatic Colorectal Cancer Using Liquid Biopsy (RAS-liquid Study): A Prospective, Multicenter Observational Study
por: Matsuda, Akihisa, et al.
Publicado: (2022)

The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
por: Freitas, Cláudia, et al.
Publicado: (2021)

Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer Centers
por: Fischer, Laura E., et al.
Publicado: (2022)

HER2 Status in RAS and BRAF Wild-Type Metastatic Colorectal Cancer: A Portuguese Study
por: Fraga, Teresa, et al.
Publicado: (2023)

Metastatic extramammary paget disease, a remarkable clinical case and a brief review of a rare disease
por: Fernandes, Leonor, et al.
Publicado: (2020)

Prevalence of Imaging-Detected Silent Female Breast Cancer in Autopsy Specimens: A Study Using Image-Guided Biopsies
por: Sidiropoulou, Zacharoula, et al.
Publicado: (2022)

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer
por: García-Foncillas, Jesús, et al.
Publicado: (2018)

Proteomics and liquid biopsy characterization of human EMT-related metastasis in colorectal cancer
por: Huang, Mao-Sen, et al.
Publicado: (2022)

Liquid biopsy can cure early colorectal cancer recurrence – Case Report
por: Baraniskin, Alexander, et al.
Publicado: (2023)

Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?
por: Mirza, Sheefa, et al.
Publicado: (2023)

Clinicopathological Profiles Associated with Discordant RAS Mutational Status between Liquid and Tissue Biopsies in a Real-World Cohort of Metastatic Colorectal Cancer
por: Brozos-Vázquez, Elena, et al.
Publicado: (2023)

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab
por: Toledo, Rodrigo A., et al.
Publicado: (2016)

Erratum: Proteomics and liquid biopsy characterization of human EMT-related metastasis in colorectal cancer
Publicado: (2022)

Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice
por: Ottaiano, Alessandro, et al.
Publicado: (2019)

Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer
por: Nicolazzo, Chiara, et al.
Publicado: (2019)

Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer
por: Gao, Wei, et al.
Publicado: (2021)

RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer
por: Maffeis, Valeria, et al.
Publicado: (2019)

Liquid Biopsies in Renal Cell Carcinoma—Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease
por: Lakshminarayanan, Harini, et al.
Publicado: (2020)

Cost-Effectiveness of Anti-Epidermal Growth Factor Receptor Therapy Versus Bevacizumab in KRAS Wild-Type (WT), Pan-RAS WT, and Pan-RAS WT Left-Sided Metastatic Colorectal Cancer
por: Lee, Shing Fung, et al.
Publicado: (2021)

Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient’s Stratification
por: Ginghina, Octav, et al.
Publicado: (2022)

Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma
por: Yang, Jin-Cui, et al.
Publicado: (2022)

Application progress of liquid biopsy in gastric cancer
por: Ma, Xiaoting, et al.
Publicado: (2022)

Case report: Liquid biopsy, the sooner the better?
por: Thomas, Quentin Dominique, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ui2f07g4hp8mivb9rmb8pvcoad